QIAGEN offers a broad range of more than 500 core products to meet the special requirements of its more than 500,000 customers worldwide. It has also developed complete instrument solutions to enable full automation of laboratory procedures, from the initial sample to the final result.
Consumables – QIAGEN’s broad range of consumables includes complete kits for predefi ned applications in sample preparation and analysis and also individual enzymes and reagents that research laboratories can use to develop their own applications. For example, the QIAGEN portfolio includes dozens of tests to detect dangerous pathogens such as infl uenza, hepatitis, HIV and tuberculosis. In addition, the GeneGlobe web portal offers scientists access to over 60,000 tests for analyzing individual genes in various species. QIAGEN consumables represent outstanding quality, reliability and comparability of results.
Instruments – As well as consumables, QIAGEN offers instruments for automating the full range of laboratory procedures, from the initial sample preparation to the final test result. This minimizes human error and increases the efficiency of workflows. These factors are particularly critical for professional laboratories which process thousands of samples a year and have very stringent requirements of the technologies they use. QIAGEN supplies more than 15 instruments, such as the QIAsymphony RGQ®, a revolutionary modular platform that has launched a new era of laboratory automation and covers the entire range of procedures from preparing a biological sample through to the final test result. In addition to other instruments for specialized laboratory applications, the company’s product range also includes systems for Point of Need tests. These allow the latest Sample & Assay Technologies to be used by customers who do not have access to a laboratory infrastructure. This is particularly important when results are needed very quickly, such as in emergency medicine.
Detection technologies – Appropriate solutions are needed for different problems. This is why QIAGEN offers a range of innovative technologies that make advances in molecular biology accessible to an ever larger number of users. Examples include:
- Polymerase chain reaction (PCR) – a method used to amplify genetic information, thus making it visible. This process delivers very precise results, a vital need when only tiny traces of the molecules being sought are present – for example in food tests, when detecting pathogens or analyzing genetic fingerprints.
- QuantiFERON® – a “pre-molecular” technology that uses the immune system’s memory to detect various diseases much sooner than other methods. It is sensitive enough to diagnose diseases at a latent stage, even before the onset of the fi rst symptoms.
- Next-generation sequencing (NGS) – a method that makes decoding genetic information much easier, faster and cheaper than conventional methods. QIAGEN’s goal is to enable the routine use of this breakthrough technology beyond life sciences research in areas such as clinical research and diagnostics.
- Pyrosequencing – a high-resolution detection technology that allows for real-time analysis of genetic mutations.